On the stock market since 2017, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
No real growth. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
The stock trades 38% below its peak. The market has trimmed its expectations for the company.
It pays out $1.20 per share each year — regular cash for whoever holds the stock.
A loss of $25.7M against -$13.2M in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, JPT sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: JPT is a high-risk stock — not yet profitable, and its future rides on its product catching on.